PPARG and glioblastoma: To address whether downregulation of BIS and 14-3-3 gamma by combined treatment with PPARγ ligands and GW9662 sensitizes glioblastoma cells towards inhibition of proliferation, we performed knockdown experiments silencing BIS and 14-3-3 gamma.